Enterprise Trust & Investment CO Gilead Sciences, Inc. Transaction History

Enterprise Trust & Investment CO

$240 Million
Q2 2022

A detailed history of Enterprise Trust & Investment CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Enterprise Trust & Investment CO holds 19,750 shares of GILD stock, worth $1.78 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

19,750

Previous 19,800 0.25%

Holding current value

$1.78 Million

Previous $1.18 Million 3.74%

% of portfolio

0.51%

Previous 0.42%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $2,886 - $3,250	-50 Reduced 0.25%	19,750 $1.22 Million
Q1 2022 Apr 08, 2022	SELL	$57.92 - $72.58 $52,128 - $65,322	-900 Reduced 4.35%	19,800 $1.18 Million
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $16,219 - $18,410	-250 Reduced 1.19%	20,700 $1.5 Million
Q3 2021 Oct 14, 2021	SELL	$67.69 - $73.03 $6,769 - $7,303	-100 Reduced 0.48%	20,950 $1.46 Million
Q2 2021 Jul 12, 2021	SELL	$63.47 - $69.35 $6,347 - $6,934	-100 Reduced 0.47%	21,050 $1.45 Million
Q1 2021 Apr 13, 2021	SELL	$60.0 - $68.46 $12,000 - $13,691	-200 Reduced 0.94%	21,150 $1.37 Million
Q4 2020 Jan 14, 2021	SELL	$56.65 - $64.55 $19,827 - $22,592	-350 Reduced 1.61%	21,350 $1.33 Million
Q3 2020 Oct 08, 2020	SELL	$62.1 - $78.08 $6,210 - $7,808	-100 Reduced 0.46%	21,700 $1.37 Million
Q2 2020 Jul 15, 2020	BUY	$72.34 - $84.0 $206,169 - $239,400	2,850 Added 15.04%	21,800 $1.68 Million
Q1 2020 Apr 06, 2020	SELL	$62.63 - $80.22 $9,394 - $12,033	-150 Reduced 0.79%	18,950 $1.42 Million
Q4 2019 Jan 07, 2020	SELL	$61.62 - $67.78 $6,162 - $6,778	-100 Reduced 0.52%	19,100 $1.24 Million
Q3 2019 Oct 02, 2019	SELL	$62.51 - $69.0 $56,259 - $62,100	-900 Reduced 4.48%	19,200 $1.22 Million
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $1.24 Million - $1.39 Million	20,100 New	20,100 $1.36 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Trust & Investment CO with notifications on news.

Account

Enterprise Trust & Investment CO Gilead Sciences, Inc. Transaction History